Otwoma noted that with over 70 percent of Kenya's HIV/AIDS, tuberculosis and malaria treatment programs reliant on ...
The Trump administration’s decision to pause U.S. foreign aid has “substantially disrupted” supply of HIV treatments in eight ...
The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...
Human resources disruptions are affecting HIV treatment services, including medicine distribution, patient management, and monitoring. DHIS2 (District Health Information Software 2) is impacted due to ...
With only 70 months left to meet the SDGs, the world faces a stark reality in the fight against AIDS, requiring urgent action ...
Health and Me on MSN2d
Yearly Jab For HIV Protection Is Now Almost HereA yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Funding Cuts: The impact of US Government funding cuts was felt immediately, leading to a shortage of staff in many clinics, which affected patient care.
Ministry of Health Flags Off Critical Human Immunodeficiency Virus (HIV) Commodities at Mission for Essential Drugs and Supplies (MEDS) ...
Clinical Trials Arena on MSN5d
Gilead to launch Phase III once-yearly HIV PrEP trial after Phase I successGilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...
An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback